![FDA, FTC and DOJ Enforcement of Medical Device Regulations FDA, FTC and DOJ Enforcement of Medical Device Regulations](https://www.fdanews.com/ext/resources/Book-Covers-2/BFFDEMDR-COVER.png?height=200&t=1685733565&width=200)
Home » First Heart Valve That Facilitates Cardiovascular Restoration Implanted in Three Pediatric Patients
First Heart Valve That Facilitates Cardiovascular Restoration Implanted in Three Pediatric Patients
![](https://www.fdanews.com/ext/resources/test/Device_Images5/StentsPlacement.gif?t=1475537045&width=430)
Xeltis has successfully implanted three pediatric patients with the first heart valve enabling cardiovascular restoration.
The patients have been enrolled in the “Xplore-I” clinical study of Xeltis bioabsorbable pulmonary heart valve, which is studied on patients from 2 to 21 years of age.
The Xeltis technology is an investigational device and is not yet approved for sale. — Cynthia Jessup
Upcoming Events
-
11Jul
-
18Jul
-
21Oct